James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed on August 2, 2005, by James Hardie Industries N.V., a foreign private issuer headquartered in Amsterdam, The Netherlands. The filing serves as a notification regarding the company's First Quarter (Q1) Fiscal Year 2006 results briefing, which was scheduled for August 19, 2005, and previously filed with the Australian Stock Exchange on July 29, 2005.
Key Financial Metrics
The provided filing text does not contain specific financial data. It acts solely as a procedural notification and does not disclose revenue, profit, cash flow, margins, debt, or liquidity figures for the period.
Material Changes
The filing text does not provide information regarding material changes in financial performance or operations compared to prior periods.
Guidance, Outlook, and Risks
The document includes a comprehensive Safe Harbor Statement regarding forward-looking statements. Management cautions that actual results may differ materially from projections due to various risks, including:
- Liabilities arising from the prior manufacture of asbestos-containing products.
- Expectations regarding payments to a special purpose fund for asbestos-related personal injury and death claims.
- Compliance with tax laws, environmental regulations, and health and safety laws.
- Market competition, product pricing, and raw material costs.
- Foreign exchange risks and international business operations.
- The successful transition of new senior management and implementation of new software systems.
Investor Verification Checklist
- Verify the actual Q1 FY06 financial results released on August 19, 2005, as this filing only notifies of the upcoming briefing.
- Review the full "Risk Factors" section in the company's Form 20-F for detailed exposure to asbestos litigation.
- Monitor updates regarding the special purpose fund for asbestos claims and associated payment expectations.
- Confirm the status of the new senior management transition mentioned in the risk factors.